Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
Abstract Aims We aimed to examine efficacy and safety outcomes of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) for the treatment of heart failure (HF), especially in patients with heart failure with preserved ejection fraction (HFpEF). Methods and results PubMed, Web of Science, and Cochrane Li...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2022-06-01
|
| Reeks: | ESC Heart Failure |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/ehf2.13905 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|